Product image of Olsar (Olmesartan Medoxomil) supplied by GNH India

Olsar

Active Ingredient:
Olmesartan Medoxomil
Origin:
EU

Olsar (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olsar, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension and is indicated for use in adults. GNH India supplies Olsar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Olsar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Menarini International Operations Luxembourg S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olmesartan medoxomil is an antihypertensive agent that works within the renin‑angiotensin‑aldosterone system to lower blood pressure.

  • Hypertension: helps achieve target blood pressure levels in adult patients.
  • Heart failure: used as part of combination therapy to improve cardiac function.
  • Diabetic nephropathy: provides renal protection by reducing intraglomerular pressure.

How It Works

  • Olmesartan medoxomil is a selective antagonist of the angiotensin II type 1 (AT1) receptor. By blocking AT1 receptors, it prevents angiotensin II‑mediated vasoconstriction, aldosterone secretion, and sympathetic activation, leading to vasodilation, reduced sodium and water retention, and ultimately lower systemic blood pressure.

Side Effects

Olmesartan medoxomil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Dizziness
  • Headache
  • Fatigue
  • Nasal congestion
  • Diarrhea

Serious or Rare Side Effects

  • Angio‑ema
  • Hyperkalemia
  • Acute kidney injury
  • Severe hypotension
  • Liver enzyme elevation

Precautions & Warnings

When prescribing Olmesartan medoxomil, clinicians should consider several safety aspects.

  • Monitor blood pressure: ensure adequate control without excessive lowering.
  • Assess renal function: adjust use in patients with impaired kidney function.
  • Check electrolytes: watch for potassium abnormalities.
  • Avoid in pregnancy: drug is contraindicated during the second and third trimesters.
  • Review concomitant medications: consider potential additive blood‑pressure effects.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Olmesartan medoxomil can interact with other medicines that affect blood pressure or renal function.

Major Interactions (Avoid)

  • Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs).
  • Potassium‑sparing diuretics or supplements (risk of hyper‑kalemia).

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) may reduce antihypertensive effect.
  • Lithium: may increase lithium levels.
  • Cyclosporine or tacrolimus: may worsen renal function.
  • Diuretics: may enhance hypotensive response.
  • Antacids containing aluminium or magnesium: may affect absorption.

Frequently Asked Questions

Olsar contains olmesartan medoxomil, an angiotensin II receptor blocker that is prescribed to lower high blood pressure in adult patients and may be part of combination therapy for heart failure or renal protection in diabetes.

Olmesartan medoxomil selectively blocks the AT1 receptor for angiotensin II, preventing vasoconstriction and aldosterone release, which leads to relaxed blood vessels, reduced fluid retention, and lower systemic blood pressure.

The appropriate dose of Olsar is determined by the prescribing clinician based on the individual’s blood pressure, response to therapy, and any co‑existing medical conditions.

Olmesartan medoxomil is contraindicated in pregnancy, especially in the second and third trimesters, due to risk of fetal toxicity. Limited data exist for breastfeeding, so use is generally discouraged unless the benefit outweighs potential risk.

To order Olsar, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Olsar belongs to the ARB class, offering blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough. Compared with other ARBs, its efficacy and safety profile are comparable, though individual response may vary.

Store Olsar below 25°C in its original packaging, protecting it from moisture, heat and direct sunlight to maintain potency.

Olsar is taken orally, usually once daily, with or without food, as directed by a healthcare professional.

Serious risks include angio‑edema, severe hypotension, hyper‑kalemia and acute kidney injury. Patients should seek immediate medical attention if they experience swelling of the face, lips or throat, dizziness, or sudden loss of kidney function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Olmesartan Medoxomil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT